Eugenodilol
Chemical compound
- None
- 1-(4-Allyl-2-methoxyphenoxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}-2-propanol
- 9930145
- 8105776
- Interactive image
- O(c1ccc(cc1OC)C\C=C)CC(O)CNCCOc2ccccc2OC
InChI
- InChI=1S/C22H29NO5/c1-4-7-17-10-11-21(22(14-17)26-3)28-16-18(24)15-23-12-13-27-20-9-6-5-8-19(20)25-2/h4-6,8-11,14,18,23-24H,1,7,12-13,15-16H2,2-3H3
- Key:NWFVEPJYORHHOG-UHFFFAOYSA-N
Eugenodilol is an alpha-1 blocker and beta blocker with weak β2-adrenergic receptor agonist activity derived from eugenol.[1]
References
- ^ Huang YC, Wu BN, Lin YT, Chen SJ, Chiu CC, Cheng CJ, Chen IJ (Jul 1999). "Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities". J Cardiovasc Pharmacol. 34 (1): 10–20. doi:10.1097/00005344-199907000-00003. PMID 10413061.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e